help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauridsen, U. B.
Right arrow Articles by Lyngsoe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauridsen, U. B.
Right arrow Articles by Lyngsoe, J.

Journal of Clinical Endocrinology & Metabolism, Vol 56, 876-882, Copyright © 1983 by Endocrine Society


ARTICLES

Effects of nonselective and beta-1-selective blockade on glucose metabolism and hormone responses during insulin-induced hypoglycemia in normal man

UB Lauridsen, NJ Christensen and J Lyngsoe

The effects of nonselective beta-blockade (propranolol) and beta-1- selective blockade (atenolol) on glucose metabolism during insulin- induced hypoglycemia were studied in eight normal subjects during constant infusion of 3-[3H]glucose. Propranolol and to a lesser extent atenolol prolonged the hypoglycemic response to insulin. After maximal hypoglycemia a significant increase in glucose uptake rate was seen after propranolol and a corresponding trend was found in the atenolol experiments. The two beta-blockers did not influence glucose production rate after insulin administration. FFA concentration declined rapidly after insulin. Propranolol delayed the subsequent normalization of FFA whereas atenolol had no significant effect. Propranolol increased epinephrine and GH responses to hypoglycemia, whereas atenolol had no effect. Neither of the two beta-blockers influenced the concentrations of glucagon, norepinephrine, and PRL. It is concluded that nonselective beta-blockade prolongs the hypoglycemic response to insulin through an increased tissue uptake of glucose which is not counteracted by an increased glucose production. It is suggested that nonselective beta- blockade increases muscle glucose uptake by lowering FFA concentrations. beta-Blocker inhibition of the antiinsulin effect of epinephrine on glucose uptake in muscle can, however, not be excluded.


This article has been cited by other articles:


Home page
Eur Heart JHome page
J.M Cruickshank
Beta-blockers continue to surprise us
Eur. Heart J., March 1, 2000; 21(5): 354 - 364.
[PDF]


Home page
ANGIOLOGYHome page
T. J. M. Cleophas and G. J. Stapper
A Pressor Effect of Noncardioselective Beta-Blockers in Mildly Hypertensive Patients During Acute Hospitalization
Angiology, February 1, 1990; 41(2): 124 - 132.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
T. J. M. Cleophas and F. H. W. Kauw
Pressor Responses from Noncardioselective Beta-Blockers
Angiology, July 1, 1988; 39(7): 587 - 596.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society